Laurus Labs Ltd

Laurus Labs Ltd | Sector: Pharmaceuticals | ISIN: INE947Q01028

₹ 331.40 (-2.24%) icon

3 Feb, 2023, 3:59:28 PM

Stock View

info icon
Edit Image

HOLD

Target | 31 Jan, 2023

450.091 (32.97%)

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company is a manufacturer of active pharmaceutical ingredients (API) for antiretroviral (ARV), oncology, c... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/3/2023 3:59:28 PM

    ₹ 331.4 -7.60 -2.24
  • Open
  • ₹ 340.9
  • Prev. Close
  • ₹ 339
  • Turnover(Lac.)
  • ₹ 4,583
  • Day's High
  • ₹ 340.9
  • Day's Low
  • ₹ 327.55
  • 52 Week's High
  • ₹ 626.3
  • 52 Week's Low
  • ₹ 324.05
  • Book Value
  • ₹ 75.12
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 17,850.89
  • P/E
  • 20.29
  • EPS
  • 16.32
  • Divi. Yield
  • 0.6

Corporate Actions

SHAREHOLDING SNAPSHOT
03 February , 2023 | 10:08 PM

PROMOTER - TOTAL27.20%

Indian: 27.20%

Foreign: 0%

NON-PROMOTER - TOTAL 72.80%

Institutions: 31.41%

Non-Institutions: 41.39%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Laurus Labs Ltd News and Update

Image not found
  • 1 day ago |
  • 2:51 PM

Decline in Molnupiravir sales to impact performance

Image not found
Image not found
Image not found
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Laurus Labs Ltd

  • CHAVA SATYANARAYANA

  • Executive Director & CEO
  • VENKATA RAVI KUMAR VANTARAM

  • Executive Director & CFO
  • Chandrakanth Chereddi

  • Executive Director
  • Aruna Bhinge

  • Independent Director
  • Rajesh Koshy Chandy

  • Independent Director
  • G Venkateswar Reddy

  • Company Sec. & Compli. Officer
  • M Venu Gopala Rao

  • Chairman & Independent Directo
  • Ravindranath Kancherla

  • Independent Director
  • Venkata Lakshmana Rao Chunduru

  • Executive Director

Summary

Laurus Labs is a fully integrated pharmaceutical and biotechnology company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology. The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others. The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh. Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The companys strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing donor-funded access-to-medicines markets of Sub-Saharan Africa, South-East Asia and Latin America. The company also has growing synthesis and nutraceutical/ cosmeceutical ingredients businesses. Further, it is increasingly focused towards growing its integrated generics finished dosage forms (FDFs) business in which it has made significant investments.Laurus Labs operates in four business lines: Generics - APIs, Generics - FDFs, Synthesis and Ingredients. Its Generics - API business comprises the development, manufacture and sale of APIs and... Read More


Reports by Laurus Labs Ltd


Reports by Laurus Labs Ltd